课题基金 / 基金详情

Stakeholder perspectives and preferences for implementation of pharmacogenomic (PGx) testing in primary care in Ontario, Canada.

Stakeholder perspectives and preferences for implementation of pharmacogenomic (PGx) testing in primary care in Ontario, Canada.
利益相关者对加拿大安大略省初级保健中实施药物基因组学 (PGx) 测试的看法和偏好。
批准号:
458553
负责人:
Cernat Alexandra
金额:
$7.65万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-11-01 至 2024-11-01

项目摘要

项目成果

Cernat Alexandra的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is increasingly understood that drug response is partly influenced by genetics. Using pharmacogenomic (PGx) testing, it is possible to determine whether individuals possess genetic variant(s) involved in drug response. Implementation of PGx testing mig
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stakeholder perspectives and preferences on the implementation of pharmacogenomic (PGx) testing in primary care in Ontario, Canada.
  • 批准号:
    457486
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $10.93万
  • 财政年份:
    2021
  • 负责人:
    Cernat Alexandra
  • 依托单位:
Costs and Cascade Health Service Use as a Consequence of Whole Genome Sequencing in Children with a Cardiomyopathy and their Families
  • 批准号:
    417980
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $1.27万
  • 财政年份:
    2018
  • 负责人:
    Cernat Alexandra
  • 依托单位:
国内基金
海外基金
Journal of Genetics and Genomics